Lightweight motor breakthrough signals major leap in EV performance and efficiency with scalable design aimed beyond ...
Euler Motors has raised Rs 437.5 crore ($47 million) in a funding round led by Lightrock, with participation from Hero ...
("Olatec"), developing one of the most clinically advanced specific oral NLRP3 inhibitors, dapansutrile, today announced that two patients have been randomized in a 12-month clinical trial, named DAPA ...
The biotechnology company administered its CTx1000 candidate to the initial patient in early-stage clinical testing for the ...
This bonkers 2024 Dallara MPS 'Macchina Posto Singolo' is heading to auction in April via RM Sotheby's, where it could fetch ...
Bosch Rexroth is expanding its portfolio for potentially explosive atmospheres. March 23, 2026 — Bosch Rexroth is expanding ...
Abstract: This article presents a novel single-phase buck-boost ac–ac converter featuring a high-frequency built-in isolation transformer (HBIT). This topology offers several distinct advantages over ...
CHANGZHOU, JIANGSU, CHINA, March 20, 2026 /EINPresswire.com/ -- In the rapidly evolving landscape of haptic feedback ...
GUANGZHOU CITY, GUANGDONG PROVINCE, CHINA, March 19, 2026 /EINPresswire.com/ -- The global electric motor industry ...
ARV-102 reduced endolysosomal and neuroinflammatory biomarkers implicated in Parkinson’s disease and progressive supranuclear palsy –– ARV-102 ...
Insmed has launched a first-in-human Phase 1 trial testing its experimental ALS gene therapy INS1202 in people with the disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results